Report Published: "Bulgaria Pharmaceuticals & Healthcare Report Q1 2014"
Political uncertainty will continue to mar any real progress in tackling funding shortages with which the Bulgarian healthcare system is grappling. While volume demand will continue to shape the development of the country's pharmaceutical market, we expect Bulgaria's wider operating environment to remain below par, in the short term at least.
View full press release